BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 19505021)

  • 1. [Role of norepinephrine in myocardial ischemia and ischemic preconditioning].
    Naumenko SE; Gilinskiĭ MA
    Usp Fiziol Nauk; 2009; 40(2):26-39. PubMed ID: 19505021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cardioprotection by anesthetics].
    Hara T
    Masui; 2006 May; 55(5):552-9. PubMed ID: 16715909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Healing the diabetic heart: does myocardial preconditioning work?
    Balakumar P; Sharma NK
    Cell Signal; 2012 Jan; 24(1):53-9. PubMed ID: 21945408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physiology and pharmacology of myocardial preconditioning.
    Raphael J
    Semin Cardiothorac Vasc Anesth; 2010 Mar; 14(1):54-9. PubMed ID: 20472628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcitonin gene-related peptide does not interact with sympathetic activity in myocardial ischemia.
    Burgdorf C; Dendorfer A; Kurz T; Richardt G
    Regul Pept; 2005 Feb; 125(1-3):99-102. PubMed ID: 15582720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Mechanisms of myocardial cell protection from ischemia/reperfusion injury and potential clinical implications].
    Lamendola P; Di Monaco A; Barone L; Pisanello C; Lanza GA; Crea F
    G Ital Cardiol (Rome); 2009 Jan; 10(1):28-36. PubMed ID: 19292017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Myocardial reperfusion: salvation or danger for the heart muscle? Stunning, hibernation and preconditioning: the states of endogenous cardiac protection against ischemia].
    Atar D
    Schweiz Med Wochenschr; 1997 Nov; 127(48):2008-13. PubMed ID: 9490468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Postconditioning: a brief review].
    Schipke JD; Kerendi F; Gams E; Vinten-Johansen J
    Herz; 2006 Sep; 31(6):600-6. PubMed ID: 17036192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Noradrenaline dynamics in prolonged ischemia after ischemic preconditioning].
    Naumenko SE; Latysheva TV; Gilinskiĭ MA
    Ross Fiziol Zh Im I M Sechenova; 2008 May; 94(5):532-8. PubMed ID: 18669358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of cardiac preconditioning: ten years after the discovery of ischemic preconditioning.
    Meldrum DR
    J Surg Res; 1997 Nov; 73(1):1-13. PubMed ID: 9441786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological preconditioning with hyperbaric oxygen: can this therapy attenuate myocardial ischemic reperfusion injury and induce myocardial protection via nitric oxide?
    Yogaratnam JZ; Laden G; Guvendik L; Cowen M; Cale A; Griffin S
    J Surg Res; 2008 Sep; 149(1):155-64. PubMed ID: 17996900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ectonucleotidase in sympathetic nerve endings modulates ATP and norepinephrine exocytosis in myocardial ischemia.
    Sesti C; Koyama M; Broekman MJ; Marcus AJ; Levi R
    J Pharmacol Exp Ther; 2003 Jul; 306(1):238-44. PubMed ID: 12676879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ischemic preconditioning attenuates cardiac sympathetic nerve injury via ATP-sensitive potassium channels during myocardial ischemia.
    Miura T; Kawamura S; Tatsuno H; Ikeda Y; Mikami S; Iwamoto H; Okamura T; Iwatate M; Kimura M; Dairaku Y; Maekawa T; Matsuzaki M
    Circulation; 2001 Aug; 104(9):1053-8. PubMed ID: 11524401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heart protection by ischemic preconditioning: a novel pathway initiated by iron and mediated by ferritin.
    Chevion M; Leibowitz S; Aye NN; Novogrodsky O; Singer A; Avizemer O; Bulvik B; Konijn AM; Berenshtein E
    J Mol Cell Cardiol; 2008 Dec; 45(6):839-45. PubMed ID: 18817783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitochondrial function: the heart of myocardial preservation.
    McFalls EO; Liem D; Schoonderwoerd K; Lamers J; Sluiter W; Duncker D
    J Lab Clin Med; 2003 Sep; 142(3):141-8. PubMed ID: 14532901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nitric oxide is a preconditioning mimetic and cardioprotectant and is the basis of many available infarct-sparing strategies.
    Cohen MV; Yang XM; Downey JM
    Cardiovasc Res; 2006 May; 70(2):231-9. PubMed ID: 16376869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toward a better understanding of the metabolic effects of ischemic preconditioning in humans.
    Dawn B; Bolli R
    J Cardiothorac Vasc Anesth; 2001 Aug; 15(4):409-11. PubMed ID: 11505340
    [No Abstract]   [Full Text] [Related]  

  • 18. Protection in the aged heart: preventing the heart-break of old age?
    Juhaszova M; Rabuel C; Zorov DB; Lakatta EG; Sollott SJ
    Cardiovasc Res; 2005 May; 66(2):233-44. PubMed ID: 15820192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preconditioning the myocardium: from cellular physiology to clinical cardiology.
    Yellon DM; Downey JM
    Physiol Rev; 2003 Oct; 83(4):1113-51. PubMed ID: 14506302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ischemic preconditioning--do we need more (pharmacological) experiments?
    de Jong JW; de Jonge R
    Basic Res Cardiol; 1997; 92 Suppl 2():48-50. PubMed ID: 9457373
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 20.